Home
>
National Drug Code (NDC)
>
Ticlopidine Hydrochloride
Ticlopidine Hydrochloride - 57664-327-86 - (Ticlopidine Hydrochloride)
Drug Information of Ticlopidine Hydrochloride
| Product NDC: | 57664-327 |
| Proprietary Name: | Ticlopidine Hydrochloride |
| Non Proprietary Name: | Ticlopidine Hydrochloride |
| Active Ingredient(s): | 250 mg/1 & nbsp; Ticlopidine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ticlopidine Hydrochloride
| Product NDC: | 57664-327 |
| Labeler Name: | Caraco Pharmaceutical Laboratories, Ltd. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075526 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020926 |
Package Information of Ticlopidine Hydrochloride
| Package NDC: | 57664-327-86 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-86) |
NDC Information of Ticlopidine Hydrochloride
| NDC Code | 57664-327-86 |
| Proprietary Name | Ticlopidine Hydrochloride |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (57664-327-86) |
| Product NDC | 57664-327 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ticlopidine Hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20020926 |
| Marketing Category Name | ANDA |
| Labeler Name | Caraco Pharmaceutical Laboratories, Ltd. |
| Substance Name | TICLOPIDINE HYDROCHLORIDE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
